Waisman Biomanufacturing

Waisman Biomanufacturing (WB) provides cGMP manufacturing services to serve biotech companies, researchers, and clinicians in the development of novel biotherapeutics for clinical trials. Since opening its cGMP facility in 2001, WB has manufactured over 320 clinical grade products and has earned a reputation for working closely with clients for cost effective and timely manufacture of quality products. We strive to meet these high standards with each product campaign. With in-depth experience in manufacturing a wide range of biotherapeutics for human clinical trials including gene therapeutics, cell therapeutics, vaccines, and recombinant proteins WB is well situated to move your therapy into...

Biotherapeutics,cell therapies,vaccines,recombinant proteins,and gene therapies

Waisman biomanufacturing operates in the Biotechnology research industry.

Waisman biomanufacturing's revenue is 11m - 100m

Waisman biomanufacturing has 11 - 50 employees.